Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Qiagen NV (QGEN)

Add to Watchlists
Create an Alert
20.96 -0.01  -0.05% NASDAQ Apr 23, 8:00PM BATS Real time Currency in USD
View Full Chart
QGEN Price Chart
View All Events

QGEN Events

Date Type Description
Jan 30 Misc QIAGEN N.V. To Report Fourth Quarter Conference Call
Jan 29 Earnings QIAGEN N.V. To Report Fourth Quarter Earnings Results. Estimate: 0.33.
Oct 29 Earnings Q3 2013 Earnings. Estimate: 0.25.
Oct 29 Misc Q3 2013 Earnings Conference Call
Jul 31 Misc Q2 2013 Earnings Conference Call
Jul 30 Earnings Publication of Quarterly Results 2/13. Estimate: 0.23.
Jun 26 Misc AGM Event for Qiagen NV
Apr 30 Misc Qiagen NV 2013 First Quarter Earnings Conference Call
Apr 29 Earnings Qiagen NV 2013 First Quarter Earnings Results. Estimate: 0.22.
View All Performance Charts

QGEN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Qiagen NV is up 2.07% over the last year vs S&P 500 Total Return up 22.59%, Affymetrix up 113.0%, and Myriad Genetics up 40.39%.

Get Quote for

PDF Report for QGEN

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download QGEN Pro Report PDF

Portfolio Strategies Featuring QGEN

Did Qiagen NV make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

QGEN Profile

  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Headquarters Country: Netherlands
  • Headquarters State/Province: N/A
  • Incorporation Country: Netherlands
  • Incorporation State/Province: N/A
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A

Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. The company's technologies focus on the following healthcare needs: Prevention, Profiling, Personalized Healthcare, and Point of Need. Consolidated under the Dutch holding Qiagen N.V., the company operates more than 30 subsidiaries in over 18 countries. Peer M. Schatz is the company’s Chief Executive Officer. The company was founded by Detlev H. Riesner, Metin Colpan, and Karsten Henco in 1984, and is headquartered in Venlo, Netherlands.

Recent Quotes

Symbol Price Chg Chg % Market Cap
QGEN 20.96 -0.01 -0.05% 4.901B
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.